Literature DB >> 12508150

Human lactoferrin impairs virulence of Shigella flexneri.

Henry F Gomez1, Theresa J Ochoa, Lily G Carlin, Thomas G Cleary.   

Abstract

Lactoferrin is a glycoprotein present in most human mucosal secretions, including human milk. Lactoferrin is bacteriostatic in low iron media and, in some settings, bactericidal. Lactoferrin impairs ability of Shigella flexneri serotype 5 strain M90T to invade HeLa cells. To determine the mechanism by which lactoferrin decreases invasiveness of Shigella organisms, its effect on the major virulence proteins responsible for bacterial uptake by host cells was evaluated. Lactoferrin induced degradation of invasion plasmid antigens IpaB and, to a lesser extent, IpaC, the key proteins responsible for bacteria-directed phagocytosis by mammalian cells. The lipid A-binding N-terminal portion of lactoferrin (residues 1-33) induces release of invasion antigens but does not induce degradation of IpaBC. Lactoferrin does not directly degrade previously released invasion plasmid antigens but works by making IpaBC susceptible to breakdown by surface-expressed protease(s).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12508150     DOI: 10.1086/345875

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  In vivo function of airway epithelial TLR2 in host defense against bacterial infection.

Authors:  Qun Wu; Di Jiang; Maisha N Minor; Richard J Martin; Hong Wei Chu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

2.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.

Authors:  Maria I Quintero-Villegas; Anja Wittke; Robert Hutkins
Journal:  Curr Microbiol       Date:  2014-06-14       Impact factor: 2.188

3.  Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.

Authors:  Henry F Gomez; Theresa J Ochoa; Irene Herrera-Insua; Lily G Carlin; Thomas G Cleary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children.

Authors:  Theresa J Ochoa; Elsa Chea-Woo; Nelly Baiocchi; Iris Pecho; Miguel Campos; Ana Prada; Gladys Valdiviezo; Angela Lluque; Dejian Lai; Thomas G Cleary
Journal:  J Pediatr       Date:  2012-08-30       Impact factor: 4.406

5.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

6.  Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli.

Authors:  David Durand; Theresa J Ochoa; Sicilia M E Bellomo; Carmen A Contreras; Víctor H Bustamante; Joaquim Ruiz; Thomas G Cleary
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

7.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 8.  Effect of lactoferrin on enteric pathogens.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Biochimie       Date:  2008-04-18       Impact factor: 4.079

9.  Travelers' diarrhea: an update on susceptibility, prevention, and treatment.

Authors:  Miguel M Cabada; A Clinton White
Journal:  Curr Gastroenterol Rep       Date:  2008-10

10.  IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin.

Authors:  Simon R Clarke; Simon J Foster
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.